Tomas Seidal

1.5k total citations
60 papers, 1.2k citations indexed

About

Tomas Seidal is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Reproductive Medicine. According to data from OpenAlex, Tomas Seidal has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 20 papers in Reproductive Medicine. Recurrent topics in Tomas Seidal's work include Ovarian cancer diagnosis and treatment (20 papers), Sarcoma Diagnosis and Treatment (15 papers) and Tumors and Oncological Cases (9 papers). Tomas Seidal is often cited by papers focused on Ovarian cancer diagnosis and treatment (20 papers), Sarcoma Diagnosis and Treatment (15 papers) and Tumors and Oncological Cases (9 papers). Tomas Seidal collaborates with scholars based in Sweden, United States and Norway. Tomas Seidal's co-authors include Ingirídur Skírnisdóttir, Lennart Angervall, Bengt Sorbe, Lars‐Gunnar Kindblom, Hector Battifora, André Balaton, B Hagmar, Joachim Mark, Sten Walther and Sten Lennquist and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and The Journal of Urology.

In The Last Decade

Tomas Seidal

60 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas Seidal Sweden 21 459 395 336 264 240 60 1.2k
Thèrése Bocklage United States 23 396 0.9× 418 1.1× 497 1.5× 227 0.9× 120 0.5× 73 1.5k
D. Schmidt Germany 23 595 1.3× 247 0.6× 620 1.8× 351 1.3× 181 0.8× 96 1.5k
Tamera J. Lillemoe United States 15 368 0.8× 446 1.1× 115 0.3× 305 1.2× 92 0.4× 28 1.0k
Ji‐Youn Sung South Korea 21 309 0.7× 478 1.2× 400 1.2× 195 0.7× 98 0.4× 90 1.4k
Chan Choi South Korea 24 395 0.9× 374 0.9× 603 1.8× 343 1.3× 106 0.4× 96 1.6k
Annette Fisseler‐Eckhoff Germany 22 631 1.4× 472 1.2× 254 0.8× 75 0.3× 139 0.6× 92 1.5k
José Antonio López‐Guerrero Spain 17 619 1.3× 439 1.1× 348 1.0× 210 0.8× 54 0.2× 55 1.2k
Shunichi Sasou Japan 14 130 0.3× 242 0.6× 235 0.7× 186 0.7× 159 0.7× 43 851
Yuko Sasajima Japan 19 225 0.5× 375 0.9× 358 1.1× 182 0.7× 251 1.0× 94 1.2k
Sun Hee Sung South Korea 20 254 0.6× 353 0.9× 365 1.1× 186 0.7× 43 0.2× 93 1.3k

Countries citing papers authored by Tomas Seidal

Since Specialization
Citations

This map shows the geographic impact of Tomas Seidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Seidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Seidal more than expected).

Fields of papers citing papers by Tomas Seidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Seidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Seidal. The network helps show where Tomas Seidal may publish in the future.

Co-authorship network of co-authors of Tomas Seidal

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Seidal. A scholar is included among the top collaborators of Tomas Seidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Seidal. Tomas Seidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seidal, Tomas, et al.. (2024). The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks. Cancer Cytopathology. 132(9). 569–579. 1 indexed citations
2.
3.
Lindquist, Kajsa Ericson, Tomas Seidal, Annika Dejmek, et al.. (2022). PD-L1 Expression in Non-Small Cell Lung Cancer Specimens: Association with Clinicopathological Factors and Molecular Alterations. International Journal of Molecular Sciences. 23(9). 4517–4517. 10 indexed citations
4.
Dejmek, Annika, et al.. (2021). Factors Influencing Concordance of PD-L1 Expression between Biopsies and Cytological Specimens in Non-Small Cell Lung Cancer. Diagnostics. 11(10). 1927–1927. 6 indexed citations
5.
Seidal, Tomas, et al.. (2021). Higher concordance of PD‐L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma. Cancer Cytopathology. 129(6). 468–478. 4 indexed citations
6.
Lindquist, Kajsa Ericson, Tomas Seidal, Lena Tran, et al.. (2021). PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens: A Comparison with Biopsies and Review of the Literature. Acta Cytologica. 65(6). 501–509. 12 indexed citations
7.
Skírnisdóttir, Ingirídur, Helena Åkerud, Tomas Seidal, & Inger Sundström Poromaa. (2019). Cell Cycle Regulator p27 Mediates Body Mass Index Effects in Ovarian Cancer in FIGO-stages I-II. Cancer Genomics & Proteomics. 16(6). 443–450. 1 indexed citations
8.
Seidal, Tomas, et al.. (2017). The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer. PLoS ONE. 12(6). e0179363–e0179363. 19 indexed citations
9.
Skírnisdóttir, Ingirídur, Tomas Seidal, & Helena Åkerud. (2016). The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I–II. International Journal of Oncology. 48(3). 998–1006. 18 indexed citations
10.
Skírnisdóttir, Ingirídur, Tomas Seidal, & Helena Åkerud. (2015). Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma. International Journal of Gynecological Cancer. 25(7). 1239–1247. 8 indexed citations
11.
Wijkander, Jonny, et al.. (2015). Macrophages of M1 phenotype have properties that influence lung cancer cell progression. Tumor Biology. 36(11). 8715–8725. 9 indexed citations
12.
Seidal, Tomas, André Balaton, & Hector Battifora. (2001). Interpretation and Quantification of Immunostains. The American Journal of Surgical Pathology. 25(9). 1204–1207. 167 indexed citations
13.
Skírnisdóttir, Ingirídur, Bengt Sorbe, & Tomas Seidal. (2001). P53, bcl-2, and bax: Their relationship and effect on prognosis in early stage epithelial ovarian carcinoma. International Journal of Gynecological Cancer. 11(2). 147–158. 25 indexed citations
14.
Skírnisdóttir, Ingirídur, Bengt Sorbe, Mats G. Karlsson, & Tomas Seidal. (2001). Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma. International Journal of Oncology. 19(6). 1295–302. 16 indexed citations
15.
Walther, Sten, et al.. (1998). Exposure to chlorine gas: effects on pulmonary function and morphology in anaesthetised and mechanically ventilated pigs. Journal of Applied Toxicology. 18(4). 249–255. 50 indexed citations
16.
Seidal, Tomas. (1991). Immunoreactivity to desmin in secretory epithelium of eccrine sweat glands. Histopathology. 18(1). 89–91. 2 indexed citations
17.
Kindblom, Lars‐Gunnar, et al.. (1991). Intermediate and fine cytofilaments in cutaneous and subcutaneous leiomyosarcomas. Apmis. 99(7-12). 820–828. 10 indexed citations
18.
Seidal, Tomas, Lennart Angervall, & Lars‐Gunnar Kindblom. (1990). Expression of muscle‐specific actins and myosin in light microscopically undifferentiated small and dark cell malignancies of soft tissues. Apmis. 98(7-12). 1105–1112. 7 indexed citations
19.
Seidal, Tomas, Lars‐Gunnar Kindblom, & Lennart Angervall. (1989). Rhabdomyosarcoma in middle‐aged and elderly individuals. Apmis. 97(1-6). 236–248. 37 indexed citations
20.
Kindblom, Lars‐Gunnar & Tomas Seidal. (1981). MALIGNANT GIANT CELL TUMOR OF THE UTERUS. Acta Pathologica Microbiologica Scandinavica Section A Pathology. 89A(1-6). 179–184. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thèrése Bocklage Breakdown of academic impact, for papers by D. Schmidt Breakdown of academic impact, for papers by Tamera J. Lillemoe Breakdown of academic impact, for papers by Ji‐Youn Sung Breakdown of academic impact, for papers by Chan Choi Breakdown of academic impact, for papers by Annette Fisseler‐Eckhoff Breakdown of academic impact, for papers by José Antonio López‐Guerrero Breakdown of academic impact, for papers by Shunichi Sasou Breakdown of academic impact, for papers by Yuko Sasajima Breakdown of academic impact, for papers by Sun Hee Sung
Rankless by CCL
2026